The high-yield clinical facts to know cold before your DHA or Gulf nursing licensing exam — normal lab values, vital signs by age, dosage-calculation formulas, fluid & electrolyte imbalance signs, ECG basics, drug antidotes, ABG interpretation, infection-control precautions, priority-setting & delegation, and a compact DHA exam blueprint, all on one scannable page. The clinical syllabus is shared across the authorities, so it applies whichever exam you sit.
Know the numbers? Test whether they stuck.
The exam rewards applying these values under time pressure — not just reading them.
| Sign | Normal range |
|---|---|
| Temperature (oral) | 36.1–37.2 °C (97–99 °F) |
| Heart rate (pulse) | 60–100 beats/min |
| Respiratory rate | 12–20 breaths/min |
| Blood pressure | < 120/80 mmHg (normal) |
| Oxygen saturation (SpO2) | 95–100% |
Hypertension is generally ≥ 130/80 mmHg; hypotension is often taken as < 90/60 mmHg.
| Age | Heart rate (bpm) | Respiratory rate (/min) |
|---|---|---|
| Newborn (0–1 month) | 100–160 | 30–60 |
| Infant (1–12 months) | 100–150 | 30–53 |
| Toddler (1–2 years) | 90–140 | 22–37 |
| Preschool (3–5 years) | 80–120 | 20–28 |
| School age (6–11 years) | 70–110 | 18–25 |
| Adolescent (12–15 years) | 60–100 | 12–20 |
Paediatric ranges differ between sources (PALS, APLS, WHO). Rates are highest in the newborn and fall towards adult values with age — confirm against the ranges your authority uses.
| Analyte | Normal range |
|---|---|
| Sodium (Na+) | 135–145 mmol/L |
| Potassium (K+) | 3.5–5.0 mmol/L |
| Chloride (Cl−) | 98–106 mmol/L |
| Calcium (total) | 2.1–2.6 mmol/L (8.5–10.5 mg/dL) |
| Ionised calcium | 1.1–1.3 mmol/L |
| Magnesium (Mg2+) | 0.7–1.0 mmol/L (1.7–2.4 mg/dL) |
| Test | Reference |
|---|---|
| Fasting glucose | 3.9–5.5 mmol/L (70–99 mg/dL) |
| Random glucose | < 7.8 mmol/L (< 140 mg/dL) |
| Diabetes (fasting) | ≥ 7.0 mmol/L (≥ 126 mg/dL) |
| HbA1c — normal | < 5.7% (< 39 mmol/mol) |
| HbA1c — prediabetes | 5.7–6.4% (39–46 mmol/mol) |
| HbA1c — diabetes | ≥ 6.5% (≥ 48 mmol/mol) |
| Analyte | Normal range |
|---|---|
| Urea | 2.5–7.1 mmol/L |
| Blood urea nitrogen (BUN) | 7–20 mg/dL |
| Creatinine | 60–110 µmol/L (0.7–1.3 mg/dL) |
Creatinine is a little lower in women and children; some labs report from ~45 µmol/L.
| Analyte | Normal range |
|---|---|
| Haemoglobin — men | 130–170 g/L (13–17 g/dL) |
| Haemoglobin — women | 120–155 g/L (12–15.5 g/dL) |
| White cells (WBC) | 4.0–11.0 ×10⁹/L |
| Platelets | 150–400 ×10⁹/L |
| Value | Normal range |
|---|---|
| pH | 7.35–7.45 |
| PaCO2 | 35–45 mmHg (4.7–6.0 kPa) |
| HCO3− | 22–26 mmol/L |
| PaO2 | 80–100 mmHg (10.7–13.3 kPa) |
| SaO2 | 95–100% |
| Test | Normal range |
|---|---|
| INR (no anticoagulant) | 0.8–1.2 |
| INR (therapeutic warfarin) | 2.0–3.0 (target varies) |
| Prothrombin time (PT) | 11–13.5 s |
| aPTT | 30–40 s |
Reference times differ by analyser and reagent; always read against the lab's own range.
| Imbalance | Key signs | Watch for |
|---|---|---|
| Hypokalaemia (< 3.5) | Muscle weakness/cramps, ↓ reflexes, fatigue, ileus/constipation | Flat T waves, U waves, digoxin toxicity risk |
| Hyperkalaemia (> 5.0) | Weakness, paraesthesia, diarrhoea, palpitations | Peaked T waves, wide QRS → cardiac arrest |
Never give IV potassium as a bolus/push — always diluted and infused. Calcium gluconate protects the heart in severe hyperkalaemia.
| Imbalance | Key signs |
|---|---|
| Hyponatraemia (< 135) | Headache, nausea, confusion, muscle cramps, seizures; correct slowly to avoid osmotic demyelination |
| Hypernatraemia (> 145) | Thirst, dry mucous membranes, restlessness/agitation, ↑ temperature, seizures if severe |
| Imbalance | Key signs |
|---|---|
| Hypocalcaemia | Tetany, +Trousseau & +Chvostek signs, tingling, laryngospasm, prolonged QT |
| Hypercalcaemia | “Stones, bones, groans, moans” — renal stones, bone pain, constipation, lethargy, weakness |
| Imbalance | Key signs |
|---|---|
| Hypomagnesaemia | Tremor, hyperreflexia, +Trousseau/Chvostek, torsades de pointes; often with low K+/Ca2+ |
| Hypermagnesaemia | ↓ reflexes (early sign), flushing, hypotension, respiratory depression, bradycardia |
| State | Key signs |
|---|---|
| Fluid volume deficit (dehydration) | ↑ HR, ↓ BP/postural drop, dry mucosa, poor skin turgor, ↓ urine output, ↑ urine specific gravity, weight loss |
| Fluid volume overload | Bounding pulse, ↑ BP, oedema, crackles/dyspnoea, distended neck veins, weight gain, ↓ urine specific gravity |
Daily weight is the most reliable measure of fluid status — 1 kg ≈ 1 litre.
Memory aid ROME: Respiratory = Opposite, Metabolic = Equal. Compensation is present when the "other" value has shifted to pull the pH back toward normal.
| Disorder | pH | PaCO2 | HCO3− |
|---|---|---|---|
| Respiratory acidosis | ↓ | ↑ | normal / ↑* |
| Respiratory alkalosis | ↑ | ↓ | normal / ↓* |
| Metabolic acidosis | ↓ | normal / ↓* | ↓ |
| Metabolic alkalosis | ↑ | normal / ↑* | ↑ |
*second arrow = compensation.
| Component | Represents / normal |
|---|---|
| P wave | Atrial depolarisation |
| QRS complex | Ventricular depolarisation; < 0.12 s (< 3 small squares) |
| T wave | Ventricular repolarisation |
| PR interval | 0.12–0.20 s (3–5 small squares) |
| QT interval | ≈ 0.36–0.44 s (varies with rate) |
Paper speed 25 mm/s: 1 small square = 0.04 s, 1 large square = 0.20 s. Rate ≈ 300 ÷ number of large squares between two R waves.
| Rhythm | Clue |
|---|---|
| Normal sinus | Rate 60–100, P before every QRS, regular |
| Sinus tachycardia | Same shape, rate > 100 |
| Sinus bradycardia | Same shape, rate < 60 |
| Atrial fibrillation | Irregularly irregular, no clear P waves |
| Atrial flutter | “Sawtooth” flutter waves |
| VT | Wide, regular, fast; may be pulseless (shockable) |
| VF | Chaotic, no organised complexes (shockable) |
| Asystole | Flat line (non-shockable) |
Drops/min (gtt/min) = (volume mL × drop factor gtt/mL) ÷ time in minutes
| Body area | % TBSA |
|---|---|
| Head & neck | 9% |
| Each arm | 9% |
| Anterior trunk | 18% |
| Posterior trunk | 18% |
| Each leg | 18% |
| Perineum / genitalia | 1% |
Children differ — the head takes a larger share (~18% in infants) and the legs less. A patient's palm (with fingers) is roughly 1% for scattered burns.
| Drug / toxin | Antidote / reversal |
|---|---|
| Opioids | Naloxone |
| Benzodiazepines | Flumazenil |
| Warfarin | Vitamin K (phytomenadione); FFP/PCC for major bleeding |
| Heparin | Protamine sulfate |
| Paracetamol (acetaminophen) | N-acetylcysteine (NAC) |
| Magnesium toxicity | Calcium gluconate |
| Hyperkalaemia (cardiac protection) | Calcium gluconate (or calcium chloride) |
| Digoxin | Digoxin-specific antibody (DigiFab) |
| Iron | Desferrioxamine (deferoxamine) |
| Beta-blocker | Glucagon |
| Organophosphates | Atropine (+ pralidoxime) |
| Many ingested poisons | Activated charcoal (if within ~1 hr, airway protected) |
These carry a heightened risk of serious harm — double-checks and independent verification are the standard safeguards.
| Precaution | Key PPE / control | Example conditions |
|---|---|---|
| Standard | Hand hygiene, gloves; gown/mask/eye protection as risk dictates | All patients, all the time |
| Contact | Gloves + gown; dedicated equipment; single room | MRSA, VRE, C. difficile (soap & water), scabies, norovirus |
| Droplet | Surgical mask within ~1–2 m; single room | Influenza, pertussis, meningococcal meningitis, mumps, rubella |
| Airborne | N95/FFP2 respirator; negative-pressure room; door closed | Tuberculosis, measles, chickenpox (varicella), disseminated zoster |
C. difficile spores are not killed by alcohol gel — wash with soap and water. COVID-19 is managed with droplet + contact precautions, escalating to airborne for aerosol-generating procedures. Confirm the current local policy at your facility.
Stable = expected findings, chronic conditions, ready-for-discharge. A patient with an expected, unchanged finding is not the priority over a new, unexpected one.
| Role | Can do | Cannot do |
|---|---|---|
| Registered Nurse (RN) | Assessment, diagnosis, planning, evaluation, teaching, first dose/blood, unstable & complex patients | — |
| LPN / Enrolled Nurse | Reinforce teaching, monitor stable patients, routine meds (per scope), dressings, ongoing data collection | Initial assessment, care plan, IV push (varies), unstable patients |
| UAP / assistant (nursing aide) | ADLs, bathing, feeding, ambulating, positioning, vitals on stable patients, intake/output, weights | Assessment, teaching, medications, evaluating care, anything with a stable→unstable change |
The “five rights” of delegation: right task, right circumstance, right person, right direction/communication, right supervision. You can delegate a task but never the accountability — assessment, teaching, evaluation and clinical judgement stay with the RN. Exact scopes vary by authority and employer; confirm locally.
| Drug | Dose / use |
|---|---|
| Adrenaline (cardiac arrest) | 1 mg IV/IO every 3–5 min (1:10,000) |
| Adrenaline (anaphylaxis) | 0.5 mg IM (1:1000), repeat after 5 min if needed |
| Amiodarone (VF/pVT) | 300 mg IV after 3rd shock; further 150 mg if needed |
| Atropine (symptomatic bradycardia) | 1 mg IV every 3–5 min, max 3 mg |
| Adenosine (SVT) | 6 mg rapid IV, then 12 mg if needed |
| Naloxone (opioid arrest) | 0.4–2 mg IV/IM/IN, titrate & repeat |
| Sign | 0 | 1 | 2 |
|---|---|---|---|
| Appearance (colour) | Blue / pale | Body pink, extremities blue | Fully pink |
| Pulse (heart rate) | Absent | < 100 bpm | ≥ 100 bpm |
| Grimace (reflex) | None | Grimace | Cry / cough / sneeze |
| Activity (tone) | Limp | Some flexion | Active motion |
| Respiration | Absent | Slow / irregular | Good / crying |
Total 0–10: 7–10 normal, 4–6 moderately depressed, 0–3 severely depressed.
| Sign | Range |
|---|---|
| Heart rate | 100–160 bpm |
| Respiratory rate | 30–60 breaths/min |
| Temperature (axillary) | 36.5–37.5 °C |
| Blood glucose | ≥ 2.6 mmol/L |
| Item | What DHA's guideline lists |
|---|---|
| Delivery | Computer-based test (CBT) at Prometric |
| Questions | 150 single-best-answer multiple-choice |
| Appointment | 3 hours (includes check-in & introduction, not just questions) |
| Pass score | 50% — except the in-active Assistant Midwife entry, which lists 45% |
| Fee | USD 240 on all four nursing entries |
Read from the DHA CBT assessment guideline stamped Updated — Sep 2026. Item counts, duration, pass score and fee can change without the document being reissued — confirm on the current PDF via Sheryan before you rely on them.
| Title | Code | Coverage |
|---|---|---|
| Registered Nurse | RNT0312 | Unit Management & Leadership · Fundamentals · Maternal–Child Nursing · Adult Nursing |
| Assistant Nurse | ARN5061 | Unit Management & Leadership · Fundamentals · Maternal–Child Nursing · Adult Nursing |
| Registered Midwife | MID5104 | Antenatal · Intrapartum · Postpartum · Newborn · Gynaecological · Pharmacology · Ethics & Legal |
| Assistant Midwife — “(In-active)” | MID5101 | Same midwifery coverage as MID5104, at a 45% pass score |
The four nursing headings are deliberately broad — they map the whole of general nursing, so the reference textbooks are the real syllabus. See the DHA syllabus & references guide for the full blueprint and book list.
This sheet is the memory layer. Go deeper with the study notes, then test recall on exam-style questions.
The Gulf nursing exam tests whether you can apply these numbers in clinical scenarios under time pressure. Practise with exam-realistic questions and worked explanations.
Unofficial study aid, not endorsed by any licensing authority, DataFlow or Prometric. Reference values are standard, well-established figures for revision — always confirm against current local clinical protocols and your exam authority before relying on them.